Tim Kutzkey is a Managing Partner at The Column Group, a venture capital firm focused on biotechnology. He leverages his Ph. D. in molecular and cell biology from UC Berkeley to build and guide early-stage life science companies, serving on the boards of several innovative therapeutic ventures.
He co-founded TCG Labs, an accelerator dedicated to partnering with scientific founders to develop new medicines.
Tim Kutzkey
Managing Partner at The Column Group
San Francisco, California, United States
Overview
Topics They Care About
Biotech Company Building
He co-founded TCG Labs, an accelerator that builds early-stage biotech companies, and serves on the boards of portfolio companies like Neurona Therapeutics and Nura Bio.
Neuroscience Therapeutics
Sits on the board of Neurona Therapeutics, a company developing cell therapies for chronic neurological disorders such as epilepsy and Parkinson's disease.
Drug Discovery
His work involves identifying and investing in novel scientific approaches to create new medicines for challenging diseases.
Media Appearances
Alumni Updates – Tim Kutzkey, Managing Partner at The Column Group. Featured in Washington Square (San Jose State University) Blog
Work History
7-2007
Managing Partner at The Column Group
7-2006 - 7-2007
Scientist at KAI Pharmaceuticals
2005 - 2006
Post-doc at UC Berkeley
Education
1999 - 2005
Ph.D. from University of California, Berkeley
1993 - 1997
Education details unavailable from Stanford University
More Information
Social Presence :
Prographics :
Exp : 21
Location : San Francisco, California, United States
Job Level : N/A
Designation : Managing Partner at The Column Group
